Who we are
About BASF Bioservices
BASF Bioservices provides end-to-end R&D services to Life Science, Biotechnology, and BASF Group companies. Our best-in-class R&D platform includes all capabilities required for biotechnology research services and product development, from discovery and screening to large scale production of microbial fermentation products, biobased chemicals, and biocatalysts.
With over 30 years of experience and more than 200 Biotech R&D experts globally, of which 50 at our San Diego site, we enable our customers to achieve their research, development, and scale-up goals, time and time again!
- Quickly engineer proteins using computational design and evolution with the end application in mind
- Automated multi-parameter parallel screening for properties like stability, titer, solubility, and application performance
- In-house next-generation sequencing supports hit selection and fast iterative learning cycles and evolution steps
- Effective functional protein diversification for purposes such as IP adaptation
- +600 million genes; +100k microbial strains; +27k successfully cloned
- Functional and digital screening with metagenomic libraries
- Real-time sequence monitoring of metagenomic libraries expands BASF collection
- Access our expertise and rich discovery collections to assist you in achieving early and later phase project success
- Research Use Only and Commercial gram +/- bacteria, yeasts and fungal strains
- Microorganism species expertise ensures the correct strain selected and optimized for downstream success
- Rapid host selection and scoping process for functional expression success
- Optimized strains are tailored to follow regulatory compliance requirements
- Custom assay development and adaptation for HTS
- First-class automation lab with multiple integrated robotic systems to fit HTS needs
- Extensive plate-based screening capabilities
- Routine collection of 10-20k data points per day
- DBTL statistical framework
- Digitalized pipeline & tracking bring interrogation of thousands of variants/drugs together
- HTP biologic excipient and pre-formulation screening
- Iterative DoE-based formulation optimization
- Stability profiling and long-term shelf-life prediction
- Biophysical and chemical lead characterization and selection within target formulations
- In-depth understanding of formulation design through our expansive analytical toolbox
- Decades of experience with state of the art upstream and downstream capabilities in both development and manufacturing
- Keeping the end process in mind, red flags are detected in early stages due to experience and expertise
- Adaptative laboratory evolution maximizes strain performance in industrial settings
- Scaling up and down technologies to ensure the success in production
If you would like to hear more about our services and how we can support you to successfully meet your innovation goals, please contact us at bioservices@basf.com
Learn more about Bioservices' workflow on this document.